Search

Hear from GSK Alumni Lindsey, Prashant, and Theresa, as they share more about their experience and where their careers have taken them.

… Friday, October 8, 2021 Three graduates, three journeys Lindsay Lindsay LaFave and Ross Levine As an undergraduate student approaching graduation at the University of Michigan, Lindsay LaFave had a sense of what she wanted to do next but wasn’t sure where her new chapter would unfold. “I was looking

Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments.

… Thursday, September 28, 2023 Memorial Sloan Kettering Cancer Center (MSK) today announced the following awards and appointments: Michel Sadelain, MD, PhD, Michel Sadelain Awarded 2024 Breakthrough Prize in Life Sciences Michel Sadelain, MD, PhD, renowned physician-scientist, Director of the Center for

Researchers from Memorial Sloan Kettering Cancer Center have begun testing for three new genetic targets and found that together they occur in approximately 50 percent of patients with squamous cell carcinomas of the lung, which affects 40,000 Americans each year. Initial findings of the research will be presented on June 4 at the 2012 American Society of Clinical Oncology (ASCO) Annual Meeting.

… Wednesday, May 16, 2012 Screening lung cancer tumor samples for cancer-causing, or “driver,” genetic mutations can help physicians tailor patients’ treatments to target those specific mutations. While scientists have identified cancer-causing mutations for the majority of lung adenocarcinomas — the most

The certification comes after a year in which hundreds of experts worked together to assess standards of care at Hartford HealthCare Cancer Institute.

… Thursday, September 18, 2014 Summary The certification comes after a year in which hundreds of experts worked together to assess standards of care at Hartford HealthCare Cancer Institute. On Tuesday, more than 40 Memorial Sloan Kettering doctors, including President and CEO Craig B. Thompson and Physician-in-Chief

Cancer biologist Andrea Ventura is the incumbent of a Geoffrey Beene Junior Faculty Chair at the Sloan Kettering Institute, he devotes his research to the nascent field of microRNA expression, seeking to understand how these small RNAs act on genes to promote or suppress cancer.

… Monday, February 1, 2010 Summary Cancer biologist Andrea Ventura is the incumbent of a Geoffrey Beene Junior Faculty Chair at the Sloan Kettering Institute, he devotes his research to the nascent field of microRNA expression, seeking to understand how these small RNAs act on genes to promote or suppress

Memorial Sloan Kettering researchers are investigating the use of tiny particles that behave like sponges to take in drugs and deliver them to tumors.

… Monday, March 10, 2014 Summary Memorial Sloan Kettering researchers are investigating the use of tiny particles that behave like sponges to take in drugs and deliver them to tumors. Memorial Sloan Kettering researchers have shown that tiny particles can be manipulated to act like sponges, taking in drugs

MSK researchers are developing a new image-generation method for PET scans. It may prove to be quicker and clearer than current scans.

… Friday, April 19, 2019 Summary MSK researchers are using computer algorithms and artificial intelligence to develop a new type of PET imaging. Recently, the first-ever image of a black hole was splashed across front pages and filled up news feeds around the world. The image was made in part thanks to

Read about new targets and tactics for treating acute myeloid leukemia.

… Monday, June 10, 2024 Ever since he was in college, Michael Rosensweig has endured a series of grueling treatments for acute myeloid leukemia (AML) . This kind of blood cancer is relentless. It moves quickly and needs aggressive, often harsh, treatment with chemotherapy , sometimes followed by a bone

MSK Kids, the pediatric oncology program at Memorial Sloan Kettering Cancer Center (MSK) has been named one of the best children’s hospitals nationally, according to U.S. News & World Report in its annual “Best Children’s Hospitals” list. MSK Kids is ranked 13th in the nation. MSK Kids has been ranked by U.S. News & World Report for the past 12 years.

… Tuesday, June 16, 2020 MSK Kids , the pediatric oncology program at Memorial Sloan Kettering Cancer Center (MSK) has been named one of the best children’s hospitals nationally, according to U.S. News & World Report in its annual “Best Children’s Hospitals” list. MSK Kids is ranked 13th in the nation.

A new resource provides a comprehensive list of human proteins that could trigger autoimmune symptoms in ‘long COVID’ patients.

… Monday, May 24, 2021 Approximately 10% of people who contract COVID-19 will develop lingering symptoms — fever, fatigue, blood clots, or brain fog — that can last for months. The underlying cause of “long COVID” is not yet known, but one hypothesis is autoimmune reactions. An autoimmune reaction occurs